News

While many oral therapies are used to treat multiple myeloma, nonadherence to oral anticancer agents continues to be a challenge.

Aside from the approved nivolumab, other immunotherapy combinations are being considered for Hodgkin lymphoma.

Optune, a noninvasive device that delivers tumor-treating fields to the brain, had been found to improve efficacy compared to chemotherapy and is well-tolerated by patients with glioblastoma multiforme (GBM).

FDA has given approval for daratumumab triplet therapy for patients with relapsed multiple myeloma

With the numbre of deaths from heart disease decreasing and the number of deaths increasing, the CDC predicts that cancer will become the leading cause of death in the US around 2016.

Members of the IHadCancer community give their insghts on what friends and family should know when sharing the holidays with a patient with cancer.

Vitamin D in women with breast cancer has been linked to a better prognosis, especially for women who are premenopausal.

Due to a dramatic reduction of risk for cervical cancer in women who have received the HBV vaccine, there may be a reduction of screening for those women.

Expert Kristin Zorn, MD discusses the importance that genetics plays in oncology, and the why genetic counseling and testing are vital.

Screening for distress, which effects 60% of patients with cancer, improve confidence in nurses and other clinicians about their ability to deliver personalized cancer care.

In order to prevent near fatal intrathecal administering of vincristine, the NCCN has launched a campaign "Just Bag It." This campaign pushes for vincristine to be stored in IV drip bags to ensure vincristine is only administered intravenously.

Richard Gralla, an expert in chemotherapy-induced nausea and vomiting (CINV), discusses how to best manage CINV in patients, including the importance of following guidelines.

Older patients with diffuse large B-cell lymphoma (DLBCL) often have an increased risk of treatment-related morbidity and mortality, but the use of preventive interventions, such as granulocyte colony-stimulating factor (G-CSF) may help.

Non-lump and non-breast symptoms of breast cancer occur for 1 in 6 women with breast cancer. For those women, patient intervals to a diagnosis of breast cancer were 1.5 times and 2 times longer.

The incidence of hepatocellular carcinoma (HCC) in patients with hepatitis B is still on the rise, making screening and surveillance in this population all the more important.

Sherry Soeder, CNP, offers practical suggestions for better survivorship care that follow the standards of care from the Comission on Cancer.

Neoadjuvant chemotherapy (NACT) in treating advanced ovarian cancer has brought improvement s to quality of life and morbidity, but there are still issues within its use, such as choosing the best candidates.

Nivolumab (Opdivo) has been granted FDA approval for the treatment of metastatic or squamous cell carcinoma of the head and neck (SCCHN).

For multiple myeloa and immunotherapy, combination treatment may be the best pathway to durable responses.

"Real Housewives of Beverly Hills" star Camille Grammer discusses how she worked to diminish the shame behind gynecologic cancers.

Brachytherapy is one of three treatments considered standard of care for women with advanced cervical cancer, and it significantly increases the chance of survival. However, less than half of patients with this disease receive standard of care.

Recent development of a tool to detect early signs of cachexia, characterized by muscle loss, anorexia and weakness, in patients with cancer may help with early diagnosis, leading to better prognosis and quality of life.

A number of risk factors can play a role in nonadherence, including older age, memory issues, and depression.

With an election and new president on the horizon, nurses and oncology professionals are wondering what will happen to Vice President Joe Biden's Cancer Moonshot.

Dr. Sundar Jagannath discusses the benefits in progression-free survival and quality of life from newly-approved therapies for patients with multiple myeloma.

Oral Care before, during and after cancer treatment.

For women with breast cancer receiving adjuvant endocrine therapy (AET), adherence may depend on socioeconomic status and out-of-pocket costs.

Genetic testing can be used to stratify the risk of a patient experiencing complications during cancer, such as venous thromboembolism (VTE).

Patients with ovarian cancer often experience recurrence which comes with its own challenges and treatments.